The study met the primary endpoint, demonstrating a complete response of 89% in the ondansetron extended release injection arm vs 82% in the standard ondansetron injection arm. Topline data were ...

PHILADELPHIA--(BUSINESS WIRE)-- Lannett Company, Inc. (AMEX: LCI), a manufacturer of generic pharmaceuticals, announced today that it has received approval from the U.S. Food and Drug Administration ...

BD Simplist Prefilled Ondansetron Injection Approved The FDA has approved BD Rx's Ondansetron Injection, the third drug from the new BD Simplist line of ready-to-administer prefilled generic ...

Teva Pharmaceutical Industries became the first company in the USA to launch a generic version of GlaxoSmithKline’s Zofran Injection this week, although others are expected to follow suit shortly ...

SAN FRANCISCO (MarketWatch) -- Teva Pharmaceutical Industries Ltd. said Wednesday the Food and Drug Administration has granted final approval for Ondansetron injection, the generic version of ...

Phase 3 study met all primary and secondary endpoints, demonstrating superior convenience, strong efficacy, and excellent safety versus conventional ondansetron injections RAICHUR, India, Nov. 11, ...

ISSUE: Hospira, Inc. announced it initiated a voluntary nationwide recall of one lot of Metoclopramide Injection, USP, 10 mg/2 mL (5 mg/mL)and two lots of Ondansetron Injection, USP, 4 mg/2 mL, (2 ...

Aurobindo Pharma has received final apprpoval from US Food and Drugs Administration to manufacture and market Ondansetron Injection 2mg/ml strength packaged in 40mg/20ml multiple dose vials and ...

The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...

Phase 3 study met all primary and secondary endpoints, demonstrating superior convenience, strong efficacy, and excellent safety versus conventional ondansetron injections This milestone underscores ...